DETERMINATION OF THE DIFFERENCES BETWEEN RALOXIFEN AND RISEDRONATE TREATMENT ON BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS | AVESİS

Kütahya Health Sciences University Research Information System

DETERMINATION OF THE DIFFERENCES BETWEEN RALOXIFEN AND RISEDRONATE TREATMENT ON BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS

Copy For Citation

Yeter A., Kavuncu V., Evcik D., Demirdal U. S.

9th European Congress on Clinical an dEconomic Aspects of Osteoporosis and Osteoarthritis, Athens, Greece, 19 - 21 March 2009, vol.20, pp.107

Publication Type: Conference Paper / Summary Text
Volume: 20
City: Athens
Country: Greece
Page Numbers: pp.107
Kütahya Health Sciences University Affiliated: No